DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association ...

Medtronic MDT continues to grab headlines with respect to its Diabetes management business update. Following two back-to-back European approvals last month for its InPen smart insulin pen as well as ...

Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...

Data collected from users of Medtronic’s InPen smart insulin pen between January 2018 and October 2020 showed that using the device slightly improved the time they spent in their target blood sugar ...

Please provide your email address to receive an email when new articles are posted on . People with diabetes who have difficulty meeting glycemic targets were better able to manage their glucose ...

Given the direct reference to Medtronic's InPen, its new campaign goes beyond just awareness and into a fully branded promotion of the tech. (Medtronic) Medtronic is turning to a celebrity endorsement ...